This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2007 Apr;6(4):294-5.

doi: 10.1016/S1474-4422(07)70064-9.

Reversibility of prion-induced neurodegeneration

PMID: 17362830
PMCID: PMC2838383
DOI: 10.1016/S1474-4422(07)70064-9

Reversibility of prion-induced neurodegeneration

Claudio Soto. Lancet Neurol. 2007 Apr.

. 2007 Apr;6(4):294-5.

doi: 10.1016/S1474-4422(07)70064-9.

Author

PMID: 17362830
PMCID: PMC2838383
DOI: 10.1016/S1474-4422(07)70064-9

No abstract available

PubMed Disclaimer

Figures

None

See this image and copyright information in PMC

Similar articles

Transmissible spongiform encephalopathies and prion protein interconversions.
Caughey B, Chesebro B. Caughey B, et al. Adv Virus Res. 2001;56:277-311. doi: 10.1016/s0065-3527(01)56031-5. Adv Virus Res. 2001. PMID: 11450303 Review. No abstract available.
Transmissible and genetic prion diseases share a common pathway of neurodegeneration.
Hegde RS, Tremblay P, Groth D, DeArmond SJ, Prusiner SB, Lingappa VR. Hegde RS, et al. Nature. 1999 Dec 16;402(6763):822-6. doi: 10.1038/45574. Nature. 1999. PMID: 10617204
Reconstructing prions: fibril assembly from simple yeast to complex mammals.
Sigurdson C, Polymenidou M, Aguzzi A. Sigurdson C, et al. Neurodegener Dis. 2005;2(1):1-5. doi: 10.1159/000086425. Neurodegener Dis. 2005. PMID: 16908997 Review.
An integrated, temporal study of the behavioural, electrophysiological and neuropathological consequences of murine prion disease.
Chiti Z, Knutsen OM, Betmouni S, Greene JR. Chiti Z, et al. Neurobiol Dis. 2006 May;22(2):363-73. doi: 10.1016/j.nbd.2005.12.002. Epub 2006 Jan 23. Neurobiol Dis. 2006. PMID: 16431123
Molecular mechanisms of prion pathogenesis.
Aguzzi A, Sigurdson C, Heikenwaelder M. Aguzzi A, et al. Annu Rev Pathol. 2008;3:11-40. doi: 10.1146/annurev.pathmechdis.3.121806.154326. Annu Rev Pathol. 2008. PMID: 18233951 Review.

See all similar articles

Cited by

Dissociation of recombinant prion protein fibrils into short protofilaments: implications for the endocytic pathway and involvement of the N-terminal domain.
Qi X, Moore RA, McGuirl MA. Qi X, et al. Biochemistry. 2012 Jun 5;51(22):4600-8. doi: 10.1021/bi300201e. Epub 2012 May 23. Biochemistry. 2012. PMID: 22591453 Free PMC article.
The intricate mechanisms of neurodegeneration in prion diseases.
Soto C, Satani N. Soto C, et al. Trends Mol Med. 2011 Jan;17(1):14-24. doi: 10.1016/j.molmed.2010.09.001. Trends Mol Med. 2011. PMID: 20889378 Free PMC article. Review.

References

1. Soto C. Unfolding the role of protein misfolding in neurodegenerative diseases. Nature Rev Neurosci. 2003;4:49–60. - PubMed
1. Prusiner SB, Scott MR, DeArmond SJ, Cohen FE. Prion protein biology. Cell. 1998;93:337–48. - PubMed
1. Aguzzi A, Polymenidou M. Mammalian prion biology: one century of evolving concepts. Cell. 2004;116:313–27. - PubMed
1. Soto C, Castilla J. The controversial protein-only hypothesis of prion propagation. Nat Med. 2004;10:S63–67. - PubMed
1. Mallucci GR, White MD, Farmer M, et al. Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron. 2007;53:325–35. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

LinkOut - more resources

Full Text Sources